{"meta":{"query_hash":"af55dc93f905","filters":{"venue":"touchREVIEWS in Respiratory & Pulmonary Diseases"},"cohort_total":5,"direct_labels_cover":0,"predictions_cover":5,"exported":5,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/af55dc93f905","api":"https://metacan.xera.ac/api/v1/cohort?venue=touchREVIEWS+in+Respiratory+%26+Pulmonary+Diseases"},"results":[{"id":"W2507086359","doi":"10.17925/usrpd.2016.01.01.19","title":"Case Report—Aspergillus Empyema Necessitans Post Double-lung Transplant","year":2016,"lang":"en","type":"article","venue":"touchREVIEWS in Respiratory & Pulmonary Diseases","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Empyema; Medicine; Parapneumonic effusion; Cystic fibrosis; Streptococcus pneumoniae; Pleural effusion; Lung; Surgery; Microbiology; Pleural fluid; Internal medicine; Antibiotics; Biology","score_opus":0.03565197958898197,"score_gpt":0.3182779664834098,"score_spread":0.2826259868944278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507086359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464643,0.011093403,0.00637225,0.009407265,0.0019744271,0.0006203705,0.0007117428,0.0004153759,0.022940844],"genre_scores_gemma":[0.9914471,0.0016340172,0.0012864668,0.0015626854,0.0018116432,0.000056029836,0.00016493721,0.000033249366,0.002003863],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9988617,0.00010812872,0.00014124259,0.00032997073,0.00015700873,0.0004020014],"domain_scores_gemma":[0.99783236,0.0004582776,0.0004890619,0.00020023108,0.00013355413,0.0008866025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047832576,0.002467078,0.002039543,0.0026876417,0.00457338,0.002504877,0.0014846927,0.007973924,0.0032680612],"category_scores_gemma":[0.00274388,0.00108522,0.0019892203,0.0016283713,0.0019730183,0.0029186876,0.0027504077,0.006032284,0.0013971645],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015209319,0.000048272974,0.0033936696,0.000017698074,0.0000065434183,0.99547654,0.00011907408,0.000034489465,0.00016654262,0.000112956506,0.00018346352,0.00042543688],"study_design_scores_gemma":[0.000005164843,0.000033105833,0.0016508074,0.000011466597,0.00000591379,0.9976355,0.00009688178,0.0000790861,0.00010780191,0.00008489572,0.00028245247,0.000006933922],"about_ca_topic_score_codex":0.002128832,"about_ca_topic_score_gemma":0.0025034097,"teacher_disagreement_score":0.007973924,"about_ca_system_score_codex":0.0017192994,"about_ca_system_score_gemma":0.0010123497,"threshold_uncertainty_score":0.012474418},"labels":[],"label_agreement":null},{"id":"W2893166950","doi":"10.17925/usrpd.2018.13.1.15","title":"Chronic Obstructive Pulmonary Disease—A Disease of Accelerated Aging","year":2018,"lang":"en","type":"article","venue":"touchREVIEWS in Respiratory & Pulmonary Diseases","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"Sanofi; AstraZeneca","keywords":"Pulmonary disease; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.04673134641038578,"score_gpt":0.3405008759235647,"score_spread":0.2937695295131789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893166950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000855604,0.32072234,0.0011433847,0.26506892,0.2576192,0.00007445455,0.00081506174,0.0005292011,0.15317185],"genre_scores_gemma":[0.009466962,0.24515642,0.0013584665,0.15595695,0.41765478,0.00010438555,0.00077604386,0.0003152724,0.16921064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99908876,0.00014861325,0.000088203225,0.00009997577,0.0004770878,0.0000973344],"domain_scores_gemma":[0.99612564,0.0017427106,0.00021374923,0.00022752055,0.0010792507,0.0006111041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009869745,0.0006264646,0.00081275456,0.0015325083,0.0008192202,0.0035154317,0.0011670247,0.003380506,0.059645295],"category_scores_gemma":[0.0048904917,0.00020795387,0.00059721636,0.0014003895,0.001320811,0.0024822755,0.001462167,0.0033354422,0.027809361],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010304812,0.000008836965,0.00016063916,0.0003612069,0.000010733248,0.00010463481,0.000039716564,0.000011947113,0.00016361046,0.0020291205,0.9292243,0.06787485],"study_design_scores_gemma":[0.000006817035,0.000016317807,0.0016007512,0.0007633491,0.000013870551,0.0005354581,0.00009981969,0.000024206087,0.00010822282,0.0037966298,0.9930253,0.00000928947],"about_ca_topic_score_codex":0.002171869,"about_ca_topic_score_gemma":0.006170471,"teacher_disagreement_score":0.059645295,"about_ca_system_score_codex":0.00089343457,"about_ca_system_score_gemma":0.0014330012,"threshold_uncertainty_score":0.1995334},"labels":[],"label_agreement":null},{"id":"W4312615811","doi":"10.17925/usrpd.2022.7.2.44","title":"Tackling ‘People Remodelling’ in Corticosteroid-dependent Asthma with Type-2 Targeting Biologics and a Formal Corticosteroid Weaning Protocol","year":2022,"lang":"en","type":"article","venue":"touchREVIEWS in Respiratory & Pulmonary Diseases","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Canadian Lung Association; Insmed; Teva Pharmaceutical Industries; Regeneron Pharmaceuticals; Sanofi; GlaxoSmithKline; Genentech; AstraZeneca","keywords":"Corticosteroid; Medicine; Asthma; Dupilumab; Mepolizumab; Immunology; Intensive care medicine; Internal medicine; Eosinophil","score_opus":0.022238175815277633,"score_gpt":0.2897002095188702,"score_spread":0.26746203370359256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312615811","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031803966,0.73452073,0.059159346,0.08969291,0.013319826,0.019908395,0.00077964104,0.000513696,0.050301567],"genre_scores_gemma":[0.17657986,0.5534797,0.14978941,0.06601954,0.012456243,0.027608294,0.0014533534,0.00016507719,0.01244847],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960639,0.0021391495,0.00082295097,0.00020926163,0.0005526933,0.00021203709],"domain_scores_gemma":[0.99599236,0.002325663,0.0006647567,0.00020817216,0.00043308304,0.0003759348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008953131,0.0006001187,0.0012408422,0.00071038026,0.00063851284,0.0014868886,0.0015452434,0.0029121935,0.004478004],"category_scores_gemma":[0.010109452,0.00023338494,0.0017188314,0.0003572573,0.0011690552,0.0015491858,0.0021798592,0.0037872598,0.0012201861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026622217,0.0015705797,0.0012476738,0.0430692,0.0007990734,0.0009142276,0.00054954976,0.0017267747,0.0051831086,0.025124963,0.037901364,0.87925124],"study_design_scores_gemma":[0.005046892,0.008522464,0.009902782,0.1000817,0.002754205,0.002985648,0.00085533474,0.0023762234,0.007325848,0.04793677,0.8120204,0.00019170826],"about_ca_topic_score_codex":0.0004535403,"about_ca_topic_score_gemma":0.0012670778,"teacher_disagreement_score":0.008953131,"about_ca_system_score_codex":0.0013580292,"about_ca_system_score_gemma":0.0039687813,"threshold_uncertainty_score":0.047349215},"labels":[],"label_agreement":null},{"id":"W4387681987","doi":"10.17925/usprd.2023.8.2.1","title":"The Excessive Carbon Footprint of Inhalers Used in Airway Disease and its Remedies","year":2023,"lang":"en","type":"article","venue":"touchREVIEWS in Respiratory & Pulmonary Diseases","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"National Institute for Health and Care Research; Regeneron Pharmaceuticals; Sanofi; GlaxoSmithKline; Canadian Lung Association; AstraZeneca","keywords":"Carbon footprint; Pulmonary disease; Greenhouse gas; Health care; Asthma; Medicine; Footprint; Intensive care medicine; Disease; Business; Airway; Conversation; Public health; Psychology; Economic growth; Nursing; Pathology; Economics; Geography; Surgery","score_opus":0.03962168096844527,"score_gpt":0.30986618412180117,"score_spread":0.2702445031533559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387681987","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015408081,0.7973885,0.0007817809,0.03197049,0.16248456,0.000020705758,0.00007161758,0.0000339779,0.005707543],"genre_scores_gemma":[0.008618214,0.8633801,0.00075228064,0.016790146,0.096686386,0.000020325684,0.000083830935,0.000051607745,0.0136170685],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979304,0.0004234454,0.0001869118,0.00024907308,0.0010646549,0.00014563037],"domain_scores_gemma":[0.997664,0.0012838704,0.00019962687,0.00006096038,0.000661914,0.00012952153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017629636,0.00081415486,0.0014055617,0.0010968925,0.000933168,0.003106057,0.0010076867,0.0035688167,0.0053499225],"category_scores_gemma":[0.0033468301,0.0002394411,0.00104826,0.0007530567,0.0013860031,0.0026464325,0.0011253817,0.0040546767,0.001999865],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017218715,0.00010843026,0.00055408996,0.013160433,0.00023118743,0.0012540868,0.0007616097,0.0003164926,0.012869019,0.014702541,0.62328535,0.33258456],"study_design_scores_gemma":[0.0000049606037,0.00008468693,0.00066695624,0.0012100756,0.000045855802,0.0008546465,0.00023598905,0.00005035636,0.001569641,0.001718273,0.9935394,0.000019263685],"about_ca_topic_score_codex":0.0008228907,"about_ca_topic_score_gemma":0.0017760205,"teacher_disagreement_score":0.0053499225,"about_ca_system_score_codex":0.001061897,"about_ca_system_score_gemma":0.0012542127,"threshold_uncertainty_score":0.017897308},"labels":[],"label_agreement":null},{"id":"W4387682039","doi":"10.17925/usprd.2023.8.2.2","title":"Camlipixant: A New Treatment Option for Refractory Chronic Cough?","year":2023,"lang":"en","type":"article","venue":"touchREVIEWS in Respiratory & Pulmonary Diseases","topic":"Respiratory and Cough-Related Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Refractory (planetary science); Adverse effect; Chronic cough; Food and drug administration; Purinergic receptor; Intensive care medicine; Drug; Pharmacology; Internal medicine; Receptor; Biology","score_opus":0.09437801332846175,"score_gpt":0.38971039991686857,"score_spread":0.2953323865884068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387682039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072057163,0.9499952,0.0009554182,0.021905264,0.0039214403,0.000052105148,0.0001251358,0.00009170861,0.015747925],"genre_scores_gemma":[0.04425575,0.9022849,0.0027603633,0.02180023,0.008040289,0.0001029531,0.00027953382,0.00003237824,0.020443588],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998965,0.000018538569,0.000008571481,0.000021543605,0.000035269917,0.000019550534],"domain_scores_gemma":[0.99991155,0.000024152045,0.00001934697,0.0000035159671,0.000013977318,0.000027544384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035325586,0.00034233084,0.00069407723,0.0006060263,0.00028308982,0.00082180864,0.00038167575,0.0009571959,0.008529889],"category_scores_gemma":[0.0002627644,0.00010820319,0.0004410584,0.0003121429,0.0003491449,0.0011942749,0.0003551101,0.0016554001,0.0029595739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008327593,0.0002576589,0.0007975786,0.0040090834,0.00011340781,0.0017590838,0.00011759999,0.00011613972,0.0131329615,0.005965942,0.06464211,0.90825564],"study_design_scores_gemma":[0.0008012916,0.0013518354,0.004596622,0.0022520912,0.00017574299,0.0064454833,0.00018402324,0.00038016093,0.0023447017,0.0044788076,0.9769415,0.00004783054],"about_ca_topic_score_codex":0.00020478868,"about_ca_topic_score_gemma":0.0011539563,"teacher_disagreement_score":0.008529889,"about_ca_system_score_codex":0.00023238773,"about_ca_system_score_gemma":0.0002764503,"threshold_uncertainty_score":0.028535366},"labels":[],"label_agreement":null}]}